Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln
17/07/2026 06:09
BRIEF-Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln July 17 (Reuters) - Sedana Medical AB (publ) SEDANA.ST:
Q2 2026 NET SALES DECREASE 1% TO 49.1 MSEK
Q2 2026 EBITDA -1.9 MSEK WITH -4% MARGIN
Source text: ID:nMFNbBTlSb
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln